Schedule
This program is among the highest-rated Harvard Medical School CME courses.
All agenda sessions are in Eastern Time.
Please note that program changes/substitutions may be made without notice.
Monday, May 3, 2027
Welcome and Introduction
9:00-9:15 am
Type 1 Diabetes: What Is New?
Screening, Diagnosis, and Staging of the Disease
9:15-9:40 am
Prevention and Treatment of Type 1 Diabetes: An Update
9:40-10:05 am
Panel Discussion and Practical Recommendations
10:05-10:45 am
Break
10:45-11:00 am
Lifestyle Modification in Diabetes, Obesity, and Related Disorders
What Do I Tell My Patient to Eat?
11:00-11:25 am
Get the Patient Moving! Exercise Recommendations
11:25-11:50 am
Panel Discussion and Practical Recommendations
11:50 am-12:30 pm
Break
12:30-1:20 pm
Incorporating Technological Advances in Diabetes Care
Continuous Glucose Monitoring: For Everyone with Diabetes?
1:20-1:45 pm
Is There a Role in Incorporating Technological Advances for People with Prediabetes or Normal Glucose Levels?
1:45-2:10 pm
Panel Discussion and Practical Recommendations
2:10-2:50 pm
Break
2:50-3:00 pm
Special Lecture
The Past, Present, and Future of Diabetes Care
3:00-3:45 pm
Tuesday, May 4, 2027
Welcome, Recap, and Introduction to Day 2
9:00-9:10 am
Obesity as the Focus for the Prevention and Treatment of Diabetes and Related Disorders
Understanding Overweight and Obesity as a Disease
9:10-9:40 am
Obesity and Cancer: Are They Truly Related?
9:40-10:10 am
Obesity and Arthritis: Is It Just More Weight on the Joints?
10:10-10:50 am
Break
10:50-11:05 am
The Emotional and Psychological Impact of Obesity
11:05-11:35 am
Panel Discussion and Practical Recommendations
11:35 am-12:15 pm
Break
12:15-1:05 pm
Prevention and Treatment of Obesity: A Hot Debate
Pharmacological Management of Obesity
1:05-1:45 pm
Surgical Management of Obesity
1:45-2:30 pm
Q and A and Practical Recommendations
2:30-3:00 pm
Special Lecture
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A 2027 Vision
3:00-3:45 pm
Wednesday, May 5, 2027
Welcome, Recap of Day 2 and Introduction to Day 3
9:00-9:10 am
Cardiovascular Disease in the Patient with Diabetes
Evaluating Cardiovascular Risk: The Role of CRP, Lp(a), Apo B and Calcium Scores
9:10-9:40 am
Evaluation and Management of Congestive Heart Failure
9:40-10:10 am
Q and A and Practical Recommendations
10:10-10:45 am
Break
10:45-11:00 am
Hypertension and Dyslipidemia Management in the Patient with Diabetes
Hypertension: Evaluation, Goals, and Current Treatment Recommendations
11:00-11:25 am
Dyslipidemia: Targets and Management Guidelines
11:25-11:50 am
Q and A and Practical Recommendations
11:50 am-12:30 pm
Break
12:30-1:20 pm
Chronic Kidney Disease in Diabetes and Metabolic Care
The Need to Thoroughly Evaluate Kidney Function: Why and How?
1:20-1:50 pm
Treatment of Chronic Kidney Disease: What Do the Guidelines Say?
1:50-2:20 pm
Q and A and Practical Recommendations
2:20-2:50 pm
Break
2:50-3:00 pm
Special Lecture
Artificial Intelligence in Diabetes Care: Fact or Fiction?
3:00-3:45 pm
Thursday, May 6, 2027
Welcome, Recap of Day 3, and Introduction to Day 4
9:00-9:10 am
Improving Diabetes Care in the Trenches
What We All Can Do to Improve the Lives of Everyone with the Disease
Opportunities to Improve Diabetes Care in Your Community
9:10-9:40 am
Question and Answer Session
9:40-10:10 am
Pharmacological Management of Diabetes: Traditional Medications
Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors)
10:10-10:40 am
Break
10:40-10:55 am
Insulin Therapy in the Patient with Diabetes
10:55-11:25 am
Q and A and Practical Recommendations
11:25 am-12:00 pm
Break
12:00-1:00 pm
Pharmacological Management of Type 2 Diabetes: SGLT-2 Inhibitors and GLP-1-Based Therapies
Perspectives from Different Medical Specialties
SGLT-2 Inhibitors: An Update from a Cardiologist's Perspective
1:00-1:35 pm
GLP-1 Receptor Agonists: An Update from an Obesity/Diabetes Perspective
1:35-2:10 pm
Mineralocorticoid Receptor Antagonists: An Update from a Nephrologist's Perspective
2:10-2:45 pm
Q and A and Practical Recommendations
2:45-3:00 pm
Closing Remarks
3:30-3:40 pm